News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
02-Mar-2005 - Scientists at the University of Southampton are continuing their pioneering research into diseases such as Creutzfeld-Jakob Disease (CJD) and related conditions caused by tiny particles known as prions, thanks to a £300,000 grant from the Medical Research Council. So far, there have been 148 ...
New company - Stirling Medical Innovations - established to develop near-patient and home use diagnostic tests based on novel biomarker technologies
02-Mar-2005 - ITI Life Sciences announced it has committed £30 million as part of a new three-year R&D programme focused on the development of new near-patient and home use diagnostic tests. Initially, the programme will focus on developing near-patient tests based on novel biomarkers (indicators) for ...
02-Mar-2005 - New data from multiple analyses support the efficacy of the investigational non-peptidic protease inhibitor tipranavir in treatment-experienced HIV-positive patients. In a 24-week analysis of the RESIST pivotal Phase III studies, treatment regimens containing tipranavir boosted with low-dose ...
02-Mar-2005 - The US government announced its support for a new British vaccine technology, which promises for the first time to provide an effective defence against botulism - the most deadly naturally occurring substance. The US National Institute of Allergy and Infectious Diseases (NIAID) part of the U.S. ...
01-Mar-2005 - Research scientists at Karolinska Institutet are planning an international initiative to map out the relationships between health, genes and lifestyle. Discussion partners include world-leading researchers from the USA, Britain, Singapore and Norway. The project has the working title ...
01-Mar-2005 - BCY LifeSciences Inc., (BCY) has signed an agreement with ALIGN Pharmaceuticals, Inc., (ALIGN) a private US based company, to undertake further development and the marketing of DCF 987. The compound is currently being developed for respiratory conditions, such as cystic fibrosis (CF). In 2004 BCY ...
01-Mar-2005 - Tibotec presented interim Phase IIB results on TMC114, a protease inhibitor (PI) studied in heavily treatment-experienced patients. Tibotec also presented data on a novel class of nucleotide-competitive reverse transcriptase inhibitors (NcRTIs). The company is also developing a compound for ...
01-Mar-2005 - BioConnection - a collaboration involving Akzo Nobel's human healthcare business, government authorities in the Netherlands and the Dutch business community - will be the first "one-stop shop" in Europe to offer start-up biopharmaceutical companies the use of dedicated and centralized production ...
01-Mar-2005 - Miltenyi Biotec GmbH announced its certification under the Agilent Technologies Certified Microarray Service Provider Program. Memorec Biotec, a subsidiary of Miltenyi Biotech focused on high-throughput gene expression profiling, has also become certified. The certification validates the ...
28-Feb-2005 - Gene Logic Inc. announced it has completed over 350 predictive toxicity assessments, using its proprietary toxicogenomics predictive models, on clients' live compounds, failed drugs and reference compounds profiled in various organ systems and primary rat hepatocytes. This genomics-based safety ...
© 1997-2024 LUMITOS AG, All rights reserved